United Kingdom· GB-APID-4369911000001100
Locoid C ointment
A medicinal product containing chlorquinaldol + hydrocortisone butyrate, registered in United Kingdom by Astellas Pharma Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Chlorquinaldol + Hydrocortisone butyrate
- Manufacturer
- Astellas Pharma Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorquinaldol + hydrocortisone butyrate in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0cdc5431-3a08-4f45-850e-f628398987ae GET /v1/drugs/0cdc5431-3a08-4f45-850e-f628398987ae?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "4369911000001100",
"desc": "Locoid C ointment (Astellas Pharma Ltd)",
"form": "Cutaneous ointment",
"vpid": "41894111000001105",
"source": "dmd",
"vtm_id": "34157811000001103",
"strength": "30 mg",
"substance": "Chlorquinaldol + Hydrocortisone butyrate",
"ingredient": "Chlorquinaldol",
"supplier_code": "2066301000001100"
}See everything about chlorquinaldol + hydrocortisone butyrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.